Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities
Net loss	$ (48,411)	$ (44,989)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	560	647
Stock-based compensation	6,484	6,530
Change in fair value of warrant liability	171	142
Non-cash change in fair value of term loan	441	(268)
Non-cash lease expense	647	619
Other	236	1
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(570)	129
Accounts payable	3,921	2,365
Accrued expenses and other liabilities	(1,393)	(1,955)
Deferred revenue	(4,288)	(4,523)
Net cash used in operating activities	(42,202)	(41,302)
Cash flows from investing activities
Purchase of property, plant and equipment	(380)	(341)
Other	71
Net cash used in investing activities	(309)	(341)
Cash flows from financing activities
Proceeds from issuance of common stock and pre-funded warrants from underwritten public offering, net of underwriting discounts and sales commissions and other offering costs	216,170	70,481
Debt issuance costs for term loan		(18)
Payment of shelf registration costs	(47)
Proceeds from common stock issuances under ESPP	75	26
Other	38	(43)
Net cash provided by financing activities	216,236	70,446
Net increase in cash, cash equivalents and restricted cash	173,725	28,803
Cash, cash equivalents and restricted cash at the beginning of the period	141,636	146,540
Cash, cash equivalents and restricted cash at the end of the period	315,361	175,343
Cash and cash equivalents	312,761	172,743
Restricted cash	2,600	2,600
Supplemental disclosure of cash flow information:
Cash paid for interest	2,586	2,655
Supplemental disclosure of noncash investing and financing activities:
Offering costs not yet paid	$ 411	$ 445